Truncated complement factor H Y402 gene therapy rescues C3 glomerulonephritis is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
From 0 citing papers with measurable signal
This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.
Learn more about DataRank methodology →Foundation Fighting Blindness Inc
Grant: BR-CMM-0615-0681-DUKE
Foundation Fighting Blindness Inc
Grant: BR-CMM-0522-0830-DUKE
National Eye Institute
Grant: P30 EY005722
National Eye Institute
Grant: R01 EY031748
NEI NIH HHS
Grant: R21 EY017128
NIGMS NIH HHS
Grant: T32 GM145449
National Institutes of Health
Research to Prevent Blindness
MeSH Terms
Keywords